Patents by Inventor Monika Patre

Monika Patre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING HER2-POSITIVE METASTATIC BREAST CANCER
    Publication number: 20220354961
    Abstract: Methods of treating patients having HER2-positive, locally advanced or previously untreated metastatic breast cancer having received prior treatment with a taxane using an anti-HER2-maytansinoid conjugate (for example trastuzumab emtansine) are provided.
    Type: Application
    Filed: July 19, 2022
    Publication date: November 10, 2022
    Applicant: GENENTECH, INC.
    Inventors: Alice Elizabeth Guardino, Meghna Samant, Alexander Strasak, Melanie Smitt, Monika Patre
  • Methods of treating HER2-positive metastatic breast cancer
    Patent number: 11406715
    Abstract: Methods of treating patients having HER2-positive, locally advanced or previously untreated metastatic breast cancer having received prior treatment with a taxane using an anti-HER2-maytansinoid conjugate (for example trastuzumab emtansine) are provided.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: August 9, 2022
    Assignee: Genentech, Inc.
    Inventors: Alice Elizabeth Guardino, Meghna Samant, Alexander Strasak, Melanie Smitt, Monika Patre
  • METHODS OF TREATING HER2-POSITIVE CANCER
    Publication number: 20210040216
    Abstract: Methods of treating patients having HER2-positive cancer are provided. Certain methods involve treatment of HER2 positive breast cancer using a programmed cell death protein 1 (PD-1) binding antagonist or a programmed death ligand 1 (PD-L1) binding antagonist in combination with trastuzumab and pertuzumab or with trastuzumab emtansine. The treatment regimen may be used in various clinical settings, for example, for treatment in the neoadjuvant or metastatic setting.
    Type: Application
    Filed: October 21, 2020
    Publication date: February 11, 2021
    Applicant: GENENTECH, INC.
    Inventors: Stephen Chui, Melanie Smitt, Monika Patre
  • METHODS OF TREATING HER2-POSITIVE METASTATIC BREAST CANCER
    Publication number: 20190030181
    Abstract: Methods of treating patients having HER2-positive, locally advanced or previously untreated metastatic breast cancer having received prior treatment with a taxane using an anti-HER2-maytansinoid conjugate (for example trastuzumab emtansine) are provided.
    Type: Application
    Filed: May 27, 2016
    Publication date: January 31, 2019
    Inventors: Alice Elizabeth Guardino, Meghna Samant, Alexander Strasak, Melanie Smitt, Monika Patre
  • METHODS OF TREATING HER2-POSITIVE CANCER
    Publication number: 20180251557
    Abstract: Methods of treating patients having HER2-positive cancer are provided. Certain methods involve treatment of HER2 positive breast cancer using a programmed cell death protein 1 (PD-1) binding antagonist or a programmed death ligand 1 (PD-L1) binding antagonist in combination with trastuzumab and pertuzumab or with trastuzumab emtansine. The treatment regimen may be used in various clinical settings, for example, for treatment in the neoadjuvant or metastatic setting.
    Type: Application
    Filed: May 15, 2018
    Publication date: September 6, 2018
    Applicant: GENENTECH, INC.
    Inventors: Stephen Chui, Melanie Smitt, Monika Patre